AI Models for Non-invasive Glycaemic Event Detection Using ECG in Type 1 Diabetics
NCT05461144 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2022-07-15
Summary
This observational study aims to recruit up to thirty T1DM patients from a diabetic outpatient clinic at the University Hospital Coventry and Warwickshire for a two-phase study. The first phase involves attending an inpatient protocol for up to thirty-six hours in a calorimetry room at the Human Metabolism Research Unit under controlled conditions, followed by a phase of free-living, for up to three days, in which participants will go about their normal daily activities without restriction. Throughout the study, the participants will wear commercially available wearable sensors to measure and record physiological signals (e.g., electrocardiogram and continuous glucose monitor). Data collected will be used to develop and validate an AI model using state-of-the-art deep-learning methods for the purpose of non-invasive glycaemic event detection.
Conditions
- Metabolic Disease
Sponsors & Collaborators
-
University of Warwick
collaborator OTHER -
University Hospitals Coventry and Warwickshire NHS Trust
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-09-30
- Primary Completion
- 2026-05-01
- Completion
- 2027-05-01
More Related Trials
-
The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men
NCT00256256 ·Status: COMPLETED ·Phase: NA
-
Prevalence of Overweight and Obesity in Adult Patients Suffering From Type 1 Diabetes
NCT05713448 ·Status: RECRUITING
-
Cooperation of Insulin and GLP-1 on Myocardial Glucose Uptake
NCT01232946 ·Status: COMPLETED ·Phase: NA
-
Low Glycemic Index Diet in Patients With Type 1 Diabetes
NCT01184703 ·Status: COMPLETED ·Phase: PHASE3
-
Glucose Variability in Subclinical Hypertrophy
NCT02748434 ·Status: TERMINATED ·Phase: NA
-
Modulation of Human Myocardial Metabolism by GLP-1 Dose Response
NCT01607450 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Intact Vagal Innervation for and Glucagon-like Peptide-1 (GLP-1) Effects
NCT01176760 ·Status: UNKNOWN ·Phase: NA
-
GLP-1 and Hypoglycemia
NCT01858896 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Evaluation of Main Determinants of Postprandial Glucose Response in Type 1 Diabetes
NCT05936242 ·Status: RECRUITING
-
Acute Changes in Plasma Glucose and Cardiovascular Disease in Diabetes
NCT05500352 ·Status: UNKNOWN ·Phase: NA
-
Effect of 48 Hours of Treatment With the Natural Peptide-Hormone GLP-1 in Patients With Chronic Heart Failure
NCT00264199 ·Status: COMPLETED ·Phase: NA
-
Hyperglucagonaemia in Patients With Type 2 Diabetes - Role of Glucagon Clearance
NCT02475421 ·Status: COMPLETED ·Phase: NA
-
A Study of LY3532226 in Participants With Type 1 Diabetes Mellitus
NCT05887999 ·Status: COMPLETED ·Phase: PHASE1
-
To Determine Tolerability to Glucagon Infusion in Obese Subjects
NCT02817659 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Low-dose Glucagon for Prevention of Exercise-Induced Hypoglycemia in People With Type 1 Diabetes
NCT05076292 ·Status: COMPLETED ·Phase: NA
-
Effect of Liraglutide on Automated Closed-loop Glucose Control in Type 1 Diabetes
NCT01856790 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Glucotoxicity and Acute Exercise
NCT01771614 ·Status: WITHDRAWN ·Phase: NA
-
Glucagon Responses During Oral- and iv Glucose in Patients With Type 1 Diabetes
NCT00704795 ·Status: UNKNOWN
-
Evaluation of Intermediate Care Clinics for Diabetes
NCT00945204 ·Status: COMPLETED ·Phase: NA
-
GLP-2 (Glucagonlike Peptide-2) and Blood Flow
NCT00540215 ·Status: COMPLETED ·Phase: NA
-
Improving Postprandial Glycaemia by a New Developed Closed-loop Control System - Closedloop4meals
NCT02100488 ·Status: COMPLETED ·Phase: NA
-
The Use of Ultrasound Detection of Lipohypertrophy to Improve Glycemic Control
NCT05377268 ·Status: RECRUITING ·Phase: NA
-
Liraglutide in Type 1 Diabetes
NCT01722240 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Dulaglutide on Glycemic Variability in Patients With Type 2 Diabetes
NCT04374578 ·Status: COMPLETED
-
A Glucometabolic Evaluation of Patients With Idiopathic Ketotic Hypoglycemia
NCT05310292 ·Status: UNKNOWN ·Phase: NA